Browse the evidence

Full PPARγ agonists (thiazolidinediones/TZDs) improve insulin sensitivity and induce white fat browning but cause adverse effects including weight gain, visceral obesity, water retention, and increased cardiovascular/bone fracture risk.

Full PPARγ drugs (TZDs) work for blood sugar but often cause weight gain and other health risks. Doctors may prescribe partial agonists or newer drugs to get the blood sugar benefits without the weight gain.

Phosphorylation of PPARγ at Ser273 selectively activates diabetic gene programs (causing insulin resistance) without affecting adipogenic or osteogenic programs, whereas Ser112 phosphorylation promotes osteogenesis.

This is a molecular mechanism. It explains why some diabetes drugs cause insulin resistance despite lowering blood sugar. Researchers are trying to block this specific phosphorylation to make better drugs.

Dietary phytoestrogens (specifically soy isoflavones) do not significantly alter circulating testosterone, free testosterone, or estradiol levels in healthy adult men, refuting concerns that soy intake causes feminization or hypogonadism.

If you are a healthy man, you can consume soy products without worrying about your testosterone levels dropping or developing feminine traits. Large-scale reviews confirm soy intake does not alter your sex hormone balance.

Obesity and metabolic dysfunction are associated with significantly elevated circulating levels of extracellular vesicles (EVs), particularly those derived from platelets, endothelial cells, and adipocytes, which serve as biomarkers for metabolic stress and insulin resistance.

If you have obesity or metabolic syndrome, your body is likely releasing higher levels of extracellular vesicles (EVs) into your blood. These are not just waste; they carry signals that can worsen insulin resistance and inflammation. While there is no direct 'EV treatment' yet, lifestyle interventions like weight loss, diet, and exercise have been shown to reduce these elevated EV levels, suggesting that managing metabolic health directly impacts this signaling pathway.

Adipose tissue-derived extracellular vesicles (EVs) mediate communication between adipose tissue and other organs (like the liver), contributing to insulin resistance and systemic metabolic dysfunction in obesity.

Your fat cells are not just storage; they send signals to your liver and other organs via tiny vesicles. In obesity, these signals can promote insulin resistance. Improving your metabolic health through diet and exercise can normalize these signals, reducing the burden on your body's regulatory systems.

Adipose tissue macrophage (ATM)-derived EVs containing miR-155 contribute to glucose intolerance and insulin resistance by suppressing adipogenic transcription factors PPARγ and CEBPβ.

Immune cells in your fat tissue send out tiny vesicles that can affect how your body handles sugar. In obesity, these vesicles may carry specific RNA molecules that worsen insulin resistance. Losing weight can change the content of these vesicles, potentially improving your metabolic health.

Liver-derived extracellular vesicles (EVs) containing specific miRNAs (let-7e-5p, miR-210-3p, miR-31-5p) are secreted in response to lipid overload and directly target adipocytes to promote adipogenesis and lipogenesis, thereby remodeling adipose tissue.

This research highlights that liver health directly influences fat storage through biological signaling, not just caloric balance. While this doesn't provide a direct lifestyle fix, it suggests that improving liver metabolic health (e.g., reducing lipid overload) may naturally reduce the drive for adipose tissue expansion.

Geranylgeranyl diphosphate synthase (Ggpps) in the liver is required for the secretion of lipid-overload-responsive EVs; liver-specific deletion of Ggpps reduces adipose mass and improves glucose tolerance.

This identifies Ggpps as a key enzyme controlling liver-to-fat signaling. Future therapies might target Ggpps to modulate fat storage, but currently, maintaining liver health through diet is the primary way to manage this pathway.

Simulated night-shift work induces 24-hour rhythms in circulating metabolites (including amino acids and lipids) that are driven by externally imposed behavioral time cues (sleep/wake, feeding/fasting) rather than the central suprachiasmatic nuclei (SCN) circadian pacemaker.

If you work night shifts, your body's metabolic rhythms (how it processes fats and proteins) are likely shifting to match your sleep and eating schedule, not your internal biological clock. This misalignment is a key driver of metabolic risk. To mitigate this, consider aligning your eating windows strictly with your awake hours (time-restricted feeding) and maintaining consistent sleep schedules, as these behavioral cues strongly influence peripheral metabolism.

Intracellular regulation of thyroid hormone by deiodinases (D1, D2, D3) dictates tissue-specific metabolic outcomes, where local T3 activation promotes energy expenditure and lipid mobilization, while inactivation preserves energy stores.

Your body's metabolic rate isn't just determined by your thyroid gland's output, but by how your specific tissues process that hormone. Enzymes called deiodinases activate or deactivate thyroid hormone locally in organs like muscle and fat. This means two people with identical blood thyroid levels can have vastly different metabolic rates and fat storage tendencies depending on their tissue-specific enzyme activity.

Brown Adipose Tissue (BAT) activity and adaptive thermogenesis are critically dependent on local Type 2 Deiodinase (D2) activity converting T4 to T3, particularly in response to cold exposure.

Exposure to cold can activate Brown Adipose Tissue (BAT), which burns calories to generate heat. This process relies on local thyroid hormone activation by the enzyme D2. While this is a potent metabolic lever, its impact varies significantly between individuals based on the amount of active BAT they possess.

Type 3 Deiodinase (D3) inactivation of thyroid hormone is essential for pancreatic beta-cell maturation and insulin secretion; D3 deficiency leads to glucose intolerance and impaired insulin secretion.

Proper regulation of thyroid hormone inactivation (by D3) in the pancreas is crucial for normal insulin secretion. Disruption of this local balance can impair beta-cell function and contribute to glucose intolerance, independent of systemic thyroid status.

Normal human aging is characterized by a significant increase in mean daily serum cortisol levels and a decrease in DHEA, leading to an elevated cortisol-to-DHEA ratio that impairs stress recovery and accelerates neurodegeneration.

As you age, your body naturally produces more cortisol (stress hormone) and less DHEA (anti-aging hormone). This imbalance impairs your ability to recover from stress and increases the risk of cognitive decline, muscle loss, and metabolic issues. Managing stress and maintaining physical activity are critical to mitigating these hormonal shifts.

Chronic elevation of glucocorticoids (cortisol) in the elderly impairs the ability to recover from stressful stimuli and contributes to structural brain changes, including hippocampal atrophy and amygdala dysfunction.

Chronic stress leads to persistently high cortisol levels, which can shrink the hippocampus (memory) and overactivate the amygdala (fear/anxiety). This impairs your ability to bounce back from stressful events. Prioritizing stress management techniques is essential for preserving cognitive function and mental health as you age.

The age-related decline in DHEA and DHEAS, combined with stable or elevated cortisol, creates a high cortisol-to-DHEA ratio that contributes to immunosenescence, frailty, and increased mortality risk.

Your body's production of DHEA (an anti-aging hormone) drops significantly with age, while cortisol (stress hormone) often stays high. This imbalance weakens your immune system and contributes to frailty. Managing stress and maintaining physical activity are key to keeping this ratio in check.

Higher baseline plasma concentrations of perfluoroalkyl substances (PFASs), specifically PFOS and PFNA, are associated with greater weight regain during the 6-24 month period following a diet-induced weight loss, primarily in women.

If you are struggling to maintain weight loss, especially as a woman, be aware that environmental chemicals like PFAS (found in non-stick cookware, food packaging, and some water supplies) may blunt your metabolic recovery. This doesn't mean you should stop trying, but it highlights why standard diets might feel harder to maintain for some. Focus on building lean muscle mass to boost RMR, as this study suggests PFAS specifically blunts the natural increase in RMR that usually helps prevent weight regain.

A single administration of senolytic CAR T cells targeting uPAR eliminates senescent cells in aged mice, resulting in improved glucose tolerance, reduced fasting glucose, and enhanced exercise capacity.

This research suggests that targeting senescent cells via a single cellular therapy can reverse age-related metabolic decline and improve physical fitness in mice. While not yet available for human use, it highlights senolytics as a potential future intervention for longevity.

Adiponectin (APN) exerts cardiovascular protective effects by activating AMPK and eNOS pathways, promoting endothelial cell survival, reducing inflammation, and inhibiting atherosclerosis progression.

Maintaining healthy adiponectin levels is crucial for heart health. Since adiponectin levels drop in obesity and diabetes, focusing on reducing visceral fat and improving insulin sensitivity through diet and exercise can help restore these protective hormonal signals. While direct supplementation is not currently standard clinical practice due to production complexities, lifestyle interventions that mimic APN's effects (like exercise-induced AMPK activation) are beneficial.

Obesity and high glucose/high lipid environments induce 'APN resistance' by disrupting the AdipoR1/caveolin signalosome, thereby diminishing the cardioprotective effects of adiponectin.

If you have diabetes or obesity, your body may become resistant to the protective effects of adiponectin. This 'APN resistance' means that simply having the hormone isn't enough; the signaling pathway is broken. Addressing the underlying metabolic stress (glucose/lipid control) is necessary to restore this protective signaling.

Sarcolemmal localization of C18:0 ceramide and specific sphingomyelin species is inversely related to insulin sensitivity in human skeletal muscle, whereas sarcolemmal 1,2-DAGs are not significantly related.

Focus on improving insulin sensitivity through exercise and metabolic health rather than just obsessing over total body fat or muscle fat content. The location and type of lipids matter more than the total amount. Endurance training appears to alter lipid localization in a way that preserves insulin sensitivity despite higher total lipid levels.

Aging is associated with reduced SIRT1 activity, which leads to decreased pVHL levels and subsequent stabilization of HIF-1α, resulting in impaired mitochondrial biogenesis and functional decline.

As you age, your body's ability to regulate oxygen-sensing pathways (specifically the SIRT1-pVHL-HIF-1α axis) changes, leading to reduced mitochondrial efficiency. While you cannot directly 'dose' this mechanism, understanding that this is a natural part of aging helps contextualize fatigue and metabolic changes. Interventions like caloric restriction or compounds like resveratrol are mentioned as potential ways to support SIRT1 activity, but the primary takeaway is that this is a complex, multi-factorial biological process.

Intermittent hypoxia (such as from Obstructive Sleep Apnea) activates NFκB and inflammatory mediators like TNF-α without sufficiently stabilizing HIF-1α, leading to chronic inflammation and disease progression.

If you have Obstructive Sleep Apnea (OSA), the intermittent drops in oxygen do not trigger the protective HIF-1α response seen in sustained hypoxia. Instead, they trigger inflammation (NFκB/TNF-α), which accelerates aging and disease. Treating OSA (e.g., with CPAP) is crucial to reducing this inflammatory burden.

Activation of AMPK during hypoxia and aging promotes mitochondrial biogenesis via PGC-1α and inhibits chronic inflammation by suppressing NFκB, thereby extending healthspan.

Activating AMPK (through exercise, caloric restriction, or compounds like metformin) supports mitochondrial health and reduces chronic inflammation. This is a key mechanism for extending healthspan and preventing age-related diseases.

Exposure to environmental obesogens (e.g., tributyltin, BPA, phthalates) increases susceptibility to obesity by altering developmental programming of stem cells and metabolic regulation, independent of caloric intake.

Minimize exposure to known obesogens like BPA (plastics), phthalates, and organotins (marine contaminants, PVC pipes). Use glass or stainless steel containers, avoid heating food in plastic, and choose fresh over processed foods to reduce intake of additives and packaging leachates, especially during pregnancy and early childhood.